IRadimed Stock

IRadimed Quick Ratio

The Quick Ratio (Acid Test) of IRadimed (IRMD) as of Aug 6, 2026 is 6.61. In the previous year, Quick Ratio (Acid Test) was 6.37 — a change of 3.75% (higher).

Quick Ratio

6.61

YoY

3.75%

Last updated:

Quick Ratio (Acid Test) of IRadimed is 2026 6.61 . Quick Ratio (Acid Test) of IRadimed was 2025 6.37 . It decreases by 3.75% higher compared to the previous year.
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

Quick Ratio (Acid Test) of IRadimed is 6.61 in 2026.

Quick Ratio (Acid Test) of IRadimed changed from 6.37 to 6.61, representing a 3.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) IRadimed since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — IRadimed

All Key Metrics — IRadimed